Chugai OTC Stock Probability of Future OTC Stock Price Finishing Over 26.38

CHGCF
 Stock
  

USD 26.38  1.35  4.87%   

Chugai Pharmaceutical's future price is the expected price of Chugai Pharmaceutical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Chugai Pharmaceutical performance during a given time horizon utilizing its historical volatility.
  
Continue to Chugai Pharmaceutical Backtesting, Chugai Pharmaceutical Valuation, Chugai Pharmaceutical Correlation, Chugai Pharmaceutical Hype Analysis, Chugai Pharmaceutical Volatility, Chugai Pharmaceutical History as well as Chugai Pharmaceutical Performance. Please specify Chugai Pharmaceutical time horizon, a valid symbol (red box) and a target price (blue box) you would like Chugai Pharmaceutical odds to be computed.

Chugai Pharmaceutical Target Price Odds to finish over 26.38

The tendency of Chugai OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 26.38 90 days 26.38 
close to 99
Based on a normal probability distribution, the odds of Chugai Pharmaceutical to move above the current price in 90 days from now is close to 99 (This Chugai Pharmaceutical probability density function shows the probability of Chugai OTC Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Chugai Pharmaceutical has a beta of 0.0829 suggesting as returns on the market go up, Chugai Pharmaceutical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Chugai Pharmaceutical will be expected to be much smaller as well. Additionally The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Chugai Pharmaceutical is significantly underperforming DOW.
   Chugai Pharmaceutical Price Density   
       Price  

Predictive Modules for Chugai Pharmaceutical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Chugai Pharmaceutical. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Chugai Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Chugai Pharmaceutical in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
25.6426.3827.12
Details
Intrinsic
Valuation
LowReal ValueHigh
25.9826.7227.46
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Chugai Pharmaceutical. Your research has to be compared to or analyzed against Chugai Pharmaceutical's peers to derive any actionable benefits. When done correctly, Chugai Pharmaceutical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Chugai Pharmaceutical.

Chugai Pharmaceutical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Chugai Pharmaceutical is not an exception. The market had few large corrections towards the Chugai Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Chugai Pharmaceutical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Chugai Pharmaceutical within the framework of very fundamental risk indicators.
α
Alpha over DOW
-0.04
β
Beta against DOW0.08
σ
Overall volatility
0.40
Ir
Information ratio 0.020783

Chugai Pharmaceutical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Chugai Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Chugai Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Chugai Pharmaceutical generated a negative expected return over the last 90 days
About 60.0% of the company shares are held by company insiders
Latest headline from english.news.cn: Japans Nikkei rebounds on BOEs bond-buying program - Xinhua

Chugai Pharmaceutical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Chugai OTC Stock often depends not only on the future outlook of the current and potential Chugai Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Chugai Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
Trailing Annual Dividend Rate55.00
Float Shares636.58M
Average Daily Volume Last 10 Day640
Average Daily Volume In Three Month1.9k
Trailing Annual Dividend Yield198.34%

Chugai Pharmaceutical Technical Analysis

Chugai Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. Chugai OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Chugai Pharmaceutical. In general, you should focus on analyzing Chugai OTC Stock price patterns and their correlations with different microeconomic environments and drivers.

Chugai Pharmaceutical Predictive Forecast Models

Chugai Pharmaceutical time-series forecasting models is one of many Chugai Pharmaceutical's otc stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Chugai Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.

Things to note about Chugai Pharmaceutical

Checking the ongoing alerts about Chugai Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Chugai Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Chugai Pharmaceutical generated a negative expected return over the last 90 days
About 60.0% of the company shares are held by company insiders
Latest headline from english.news.cn: Japans Nikkei rebounds on BOEs bond-buying program - Xinhua
Continue to Chugai Pharmaceutical Backtesting, Chugai Pharmaceutical Valuation, Chugai Pharmaceutical Correlation, Chugai Pharmaceutical Hype Analysis, Chugai Pharmaceutical Volatility, Chugai Pharmaceutical History as well as Chugai Pharmaceutical Performance. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Chugai OTC Stock analysis

When running Chugai Pharmaceutical price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Is Chugai Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chugai Pharmaceutical. If investors know Chugai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chugai Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chugai Pharmaceutical is measured differently than its book value, which is the value of Chugai that is recorded on the company's balance sheet. Investors also form their own opinion of Chugai Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Chugai Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chugai Pharmaceutical's market value can be influenced by many factors that don't directly affect Chugai Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chugai Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Chugai Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chugai Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.